These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 13146896)

  • 1. [Mesantoin and severe bone marrow aplasias].
    HOLTEN C
    Ugeskr Laeger; 1954 Feb; 116(7):256-7. PubMed ID: 13146896
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe drug reaction with bone marrow depression due to mesantoin.
    LUPAS JA
    J Okla State Med Assoc; 1962 Oct; 55():409-11. PubMed ID: 13931744
    [No Abstract]   [Full Text] [Related]  

  • 3. [Two cases of panmyelopathy caused by drugs].
    PAPP O; ABERLE L; BAN A; HARASZTI A
    Orv Hetil; 1954 Apr; 95(16):446-7. PubMed ID: 13166319
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fatal pancytopenia caused by mesantoin therapy].
    KOSKINEN P
    Duodecim; 1953; 69(7-8):644-7. PubMed ID: 13107579
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental production of lymph node swellings by feeding of mesantoin].
    KASLARIS E
    Wien Klin Wochenschr; 1953 Dec; 65(50):1007-8. PubMed ID: 13147158
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lymph node swellings after mesantoin medication and their cytological picture].
    BODART F
    Wien Z Inn Med; 1953 Oct; 34(10):375-9. PubMed ID: 13137057
    [No Abstract]   [Full Text] [Related]  

  • 7. [Complications in mesantoin therapy of epilepsy].
    ANDERSSON B
    Sven Lakartidn; 1953 Feb; 50(9):482-4. PubMed ID: 13077237
    [No Abstract]   [Full Text] [Related]  

  • 8. [Manifestations of mesantoin reactions].
    LEIBETSEDER F; ZELGER J
    Z Haut Geschlechtskr; 1954 Dec; 17(11):337-42. PubMed ID: 14374869
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mesantoin injury and infectious mononucleosis].
    IPPEN H
    Dtsch Med Wochenschr; 1959 Apr; 84(14):683-6. PubMed ID: 13639711
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute nephrotic syndrome caused by mesantoin treatment].
    HOFLE KH; SCHOOP W
    Dtsch Med Wochenschr; 1959 Apr; 84(17):837-8. PubMed ID: 13652662
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatal pancytopenia as a result of improperly supervised mesantoin therapy.
    BURRELL ZL
    Am Pract Dig Treat; 1955 May; 6(5):726-8. PubMed ID: 14361960
    [No Abstract]   [Full Text] [Related]  

  • 12. [Regular blood counts after treatment with mesantoin & dimedione].
    KIORBOE E; KROMANN K
    Nord Med; 1958 Nov; 60(45):1599-602. PubMed ID: 13613564
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukopenia and scarlatiniform exanthema resulting from medication with mesantoin.
    BJØRNSTAD R
    Acta Derm Venereol; 1953; 33(5):425-7. PubMed ID: 13113826
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bone marrow injuries by modern anticonvulsants: hydantoins and tridione].
    MEIER U
    Dtsch Med Wochenschr; 1953 Aug; 78(33-34):1107-9. PubMed ID: 13083197
    [No Abstract]   [Full Text] [Related]  

  • 15. [Another case of importance bone-marrow lesion by mesantoin].
    WEINMANN O
    Wien Klin Wochenschr; 1951 Feb; 63(7):139. PubMed ID: 14836617
    [No Abstract]   [Full Text] [Related]  

  • 16. Mesantoin and pulmonary changes.
    Goffman TE; Dicicco BS; Tsou E
    Ann Intern Med; 1982 Feb; 96(2):254-5. PubMed ID: 7059081
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bone marrow aplasias].
    James JM
    Soins; 1984 Mar; (426):37-41. PubMed ID: 6564721
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mesantoin side-effects with Addison pigmentation and cerebral seizure rhythm].
    Gottwald W; Aksoy F
    Hautarzt; 1965 Oct; 16(10):445-9. PubMed ID: 5866254
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bone marrow aplasias and their treatments].
    Boiron M; Gluckman E
    Acquis Med Recent; 1981; 198():201-17. PubMed ID: 7315164
    [No Abstract]   [Full Text] [Related]  

  • 20. [The injurious effect of hydantoins on bone marrow with reference to a fatal panmyelophthisis following sacerno (3-methyl 5, 5-phenylethylhydantoin) therapy].
    BAN A; BERCZELLER I
    Orv Hetil; 1952 Apr; 93(16):480-4. PubMed ID: 13003265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.